Introduction
A large number of compounds from many different chemical classes are reported in the literature as interfering with DNA-processing enzymes [1, 2] or being DNA-intercalating agents [1, 3, 4] .
Some derivatives of the pyrazolo [5,1-c] [1, 2, 4] benzotriazine system have been extensively studied in our laboratory as benzodiazepine receptor ligands [5] . In a previous paper [6] we reported some variously substituted derivatives of this system which exhibited antitumor properties in vitro against leukemia cells more than against solid tumors; the nitromoiety appeared essential for the cytotoxic activity. Synthesis and biological evaluation of a new series of 3-nitropyrazolo[5,1c] [1, 2, 4] benzotriazine derivatives 1-4 bearing other substitutions with electron-drawers or electron-donors in the 7 and/or 8 position are reported here.
The aim of the present research was to investigate if these substitutions might improve the cytotoxic activity on solid tumors. Mitomycin C, doxorubicin and compound 5 (3-cyano-8-chloropyrazolo[5,1-c][1,2,4]benzo-triazine 5-oxide) [6, 7] were selected as reference compounds. The latter compound, which we previously synthesized [7] , has been selected for anti-HIV and anticancer tests at the National Cancer Institute (NCI) [8] . This compound showed remarkable anti-proliferative activity against various human tumor cell lines (IC 50 s ranging from 10 -5 to 10 -6 M) (unpublished data, see mean graph from the NCI [8]).
The in vitro inhibitory effects of the study compounds on the growth of human cancer cell lines (i.e. HT29 and HCT-8, colon carcinomas, MCF7, breast carcinoma, and A549, lung carcinoma cells) were assessed by the sulforhodamine (SRB) B assay [9] . Also, the effects of these compounds on cell cycle distribution of human colon carcinoma cells (HCT-8) were analyzed by flow cytometry [10] .
Materials and methods

Chemical compounds 1-4
New compounds 1-4 were synthesized according to our previously reported procedure [7] . The starting materials were represented by 1-(2-nitrophenyl)-5-aminopyrazole-4-carboxylate with the appropriate substituent on the phenyl ring in the 4 and 5 position. These compounds cyclize to pyrazolo [5,1-c] [1, 2, 4] benzotriazine 5-oxide under alkaline conditions. After decarboxylation and nitration of the 3 position, under standard conditions, we obtained the desired compounds 1-4.
The structures of the new compounds and new intermediates were confirmed by 1 H nuclear magnetic resonance and IR spectroscopy. The other experimental data are reported in Table 1 . Compounds were solubilized in dimethylsulfoxide (DMSO) at 100 times the desired maximum test concentration (maximum final DMSO concentration of 0.1%; this concentration was not toxic) and stored frozen. Compounds were then diluted with complete media to obtain the 10 times desired final maximum test concentration. Additional serial dilutions were made to provide a total of five drug concentrations plus control. Aliquots of 20 ml of these different drug dilutions were added to the appropriate microtiter wells already containing 180 ml of medium, resulting in the required final drug concentrations. All chemicals were purchased from Sigma (St Louis, MO) unless otherwise specified.
Cell cultures
The cell lines used in this study were two human colon carcinoma cell lines (HT29 and HCT8), one breast carcinoma (MCF7) and one lung carcinoma (A549) cell line, obtained from the ATCC (Rockville, MD). The HT29, HCT8 and MCF7 cell lines were maintained in RPMI 1640 (Euroclone, Wetherby, UK) supplemented with 10% fetal calf serum (FCS) (Euroclone) and antibiotics (penicillin 100 U/ml and streptomycin 100 mg/ml). The A549 cell line was maintained in F12 (Euroclone) medium supplemented with 10% FCS and antibiotics. All cell lines were incubated at 371C, 5% CO 2 /95% air and subcultured twice weekly. The cells had similar doubling times, varying between 20 and 25 h.
Cell growth inhibition studies
Exponentially growing cells were inoculated into 96-well microtiter plates at plating densities of 3000 cells/well. After cell inoculation, the microtiter plates were incubated at 371C, 5% CO 2 /95% air and 100% relative humidity for 24 h prior to the addition of experimental drugs. After 24 h, medium was removed and replaced with appropriate medium containing varying doses of experimental agents for 4, 24 and 72 h. After 4-and 24-h treatments, samples were washed and incubated for an additional 72 h in drug-free medium at 371C, 5% CO 2 / 95% air and 100% relative humidity. According to the procedure described by Skehan et al. [9] , the assay was terminated by the addition of cold TCA. Cells were fixed in situ by 10% TCA and stained by SRB solution at 0.4% (w/v) in 1% acetic acid. After staining, unbound dye was removed by washing 5 times with 1% acetic acid and the plates were air dried. Bound stain was subsequently solubilized with 10 mM Tris base and the absorbance was read on an automated plate reader at a wavelength of 540 nm. The IC 50 drug concentrations resulting in a 50% reduction in the net protein increase (as measured by SRB staining) in control cells during the drug incubation were determined after a 72-h exposure and at 72 h following 4-and 24-h exposures to compounds and subsequent washout.
Cell cycle analysis
HCT-8 cells were exposed to agents at concentrations of the test compounds equal to IC 50 of a 72-h continuous exposure. At different times (24, 48 and 72 h), floating cells were collected, adherent cells were trypsinized and pooled with the floating ones, and then fixed in 70% ice-cold ethanol and stored at 41C. Cells were then rehydrated in phosphate-buffered saline and stained with propidium iodide (PI, 50 mg/ml) solution containing RNase A (5 U/ml) for 30 min [10] . PI-stained cells were analyzed for DNA content with a FACStar cell sorter (Becton Dickinson, Mountain View, CA) equipped with an argon ion laser (Model Innova 90; Coherent, Palo Alto, CA) operating at 500 mW output at 488 nm. The red fluorescence emitted by PI was collected by a 620-nm long-pass filter, recorded as a measure of the amount of DNA-bound PI and displayed on a linear scale. Data from 20 000 cells were analyzed with forward and scattered light, and red fluorescence was recorded with Consort 30 software. Non-cellular material was excluded from the analysis by gating side angle and forward angle light scattering characteristics of each sample so that we could assume that cells with a DNA content less than 2n that appeared during the time course were apoptotic cells. 
Results
Cell growth-inhibitory effects Table 2 and Fig. 1 .
Cytotoxicity after a 4-h exposure
After a short-term exposure, in HCT-8 and MCF7 cells IC 50 values ranged from 3.6 to 9.4 mM for all compounds, with the exception of compound 4 in HCT-8 cells and compound 5 in MCF7 cells (IC 50 > 10 mM); in HT29 and A549 cells all compounds exhibited IC 50 > 10 mM. All cell lines were highly sensitive to DOX and MMC, with IC 50 values ranging from 0.2 and 0.5 mM.
Cytotoxicity after a 24-h exposure
After an intermediate exposure, HCT-8 cells displayed a similar degree of sensitivity to all study compounds (IC 50 values ranging from 2.3 to 4.5 mM). MCF7 cell line exhibited IC 50 values between 1.8 and 6.4 mM, but was not sensitive to compound 5 (IC 50 > 10 mM). Prolongation of exposure time induced a higher degree of sensitivity to study compounds also in HT29 and A549 cells (IC 50 values ranging from 2.3 to 7.0 mM), with the exception of compound 5 (IC 50 > 10 mM). IC 50 values for DOX and MMC ranged from 0.07 and 0.13 mM in all cell lines.
Cytotoxicity after a 72-h exposure
After a long-term exposure, the inhibitory cell growth effects of study compounds were similar in all cell lines and ranged from 1.6 and 4.6 mM. HT29 and A549 cells remained not sensitive to compound 5 (IC 50 > 10 mM). IC 50 values for DOX and MMC ranged from 0.05 and 0.09 mM in all cell lines.
Cell cycle effects
Analysis of cell cycle perturbations induced by study compounds was performed on a representative cell line (HCT-8). 
Morphological effects
Detached HCT8 cells were collected 48 h following incubation with 72-h IC 50 s of the study compounds. These cells showed an apoptotic morphology with compacted and fragmented nuclei when compared with attached control cells where the chromatin was diffuse (Fig. 3a) . Moreover, 58-80% of detached cells excluded Trypan blue 48 h after exposure to IC 50 agent values, meaning that their membranes remained intact. Figure  3(b and c) illustrates the percentage of HCT-8 cells with sub-G 0 /G 1 DNA content calculated on the total cell population 48 h after drug exposure; at this time we had a higher number of floating cells. Spontaneous apoptosis was observed in the 0.5% of the control cells with 16% of cell debris. Only minimal, non-significant increases in the percentage of HCT-8 apoptotic cells were observed with study compounds and control drugs, ranging from 0.9 to 2.5%. On the contrary, abundant cellular debris, as demonstrated by the DNA histograms, was present, ranging from 27 to 41%.
Discussion
Previous investigations have already revealed favorable cytotoxic properties for some 3-nitropyrazolo[5,1c] [1, 2, 4] benzotriazine derivatives, especially against leukemia cells, and low cytotoxic activity against solid tumors [6] . This further stimulated our interest, and thus we continued our investigation with the synthesis and study of this new class of 3-nitropyrazolo[5,1-c] In all tumor cell lines tested, the growth-inhibitory effects of the study compounds were dependent on both drug concentrations and exposure times.
The differences in sensitivity to study compounds observed in the various cell lines after a short-term exposure (4 h) became less pronounced following longerterm exposures (24 and 72 h). When HT29 and A549 cells were exposed to study compounds for 4 h, 50% cell growth inhibition was not achieved even at the highest concentration tested (10 mM). The same result was observed in HCT-8 and MCF7 cells with short-term exposure to compounds 4 and 5. Increasing the exposure time from 4 to 24 h notably decreased the IC 50 values observed for all cell lines, whereas an increase in the exposure time from 24 to 72 h only slightly decreased the IC 50 values for the four cell lines.
We also studied the cell kinetic perturbations produced by in vitro exposure to study compounds of one representative tumor cell line (HCT-8). At 72-h IC 50 values, this resulted in cell cycle perturbations comparable to those of MMC and DOX, except for compound 3 which induced a marked accumulation of cells into the S phase with a concomitant decrease in G 0 / G 1 and G 2 /M phases.
Since apoptosis is a major mode of cell death induced by several DNA-damaging agents [11] , we evaluated the induction of apoptosis of colon carcinoma cells (HCT-8) treated with IC 50 values of the study compounds. Apoptotic cells were detected as the population of cells with sub-G 0/ G 1 DNA content. Further analysis by fluorescent microscopy of the PI-stained detached cell morphology helped us to confirm the presence of apoptotic cells in the cell culture which may be the same recorded with flow cytometry as the sub-G 0/ G 1 DNA peak. Previous studies by other authors have shown that only detached cells exhibit apoptotic morphology, while attached treated cells have a morphology similar to that of attached untreated control cells [12] [13] [14] .
Our results indicate the presence of a modest percentage (up to 2.5%) of cells with sub-G 0/ G 1 DNA content in all samples after a 48-h exposure to agents. On the other hand, the presence of abundant cellular debris, provided by the DNA histograms, suggests cell killing. One possible explanation is that all compounds induce extensive fragmentation of DNA, generating very small DNA fragments or single nucleotides that cannot be detected with flow cytometry.
In conclusion, this study has demonstrated that 3nitropyrazolo[5,1-c] [1, 2, 4] benzotriazine derivatives possess cytotoxic activity in the micromolar range against human tumor cell lines under aerobic conditions. This activity is similar or even improved as compared to 3-cyano-8-chloropyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide 5, previously synthesized in our laboratory, but significantly lower than that of DOX and MMC. The effects on the cell cycle induced by the 3-nitropyrazolo[5,1-c] [1, 2, 4] benzotriazine derivatives were, however, similar to those of DOX (e.g. compounds 1, 3 and 4) and MMC (e.g. compounds 2 and 5). These results do not necessarily imply that the cytotoxic mechanism of the tested compounds is similar to that of DOX or MMC, but the structural features of these agents suggest that DNA may be one of the targets of their cytotoxic action. Although these data do not provide an explanation for the anti-proliferative effects of 3-nitropyrazolo[5,1-c] [1, 2, 4] benzotriazine derivatives, they confirm the critical role of the nitro group on cytotoxicity independently of substituents in positions 7 and 8. These results warrant further investigations to clarify pathways through which alterations of the cell cycle lead to cell growth inhibition.
